AiimSense

What AiimSense does

AiimSense Inc. is a Canadian privately held medical device company founded in 2019 and headquartered in Waterloo, Ontario, with a secondary office in Calgary, Alberta. The company has 11–50 employees and operates as a pre-commercial startup. Its sole product is BrainScreen™, a lightweight, portable brain scanner that combines electromagnetic imaging (EMI) — using safe, low-power radiation to detect real-time changes in brain dielectric properties — with proprietary AI algorithms to identify strokes (ischemic and hemorrhagic) and traumatic brain injuries at the point of care. The device is designed to deliver diagnostic insight in minutes and to operate in settings where CT and MRI are unavailable, impractical, or too slow.

The company targets healthcare institutions directly, with primary customer segments spanning emergency departments (ER/ICU), pre-hospital EMS/ambulance services, rural and underserved communities, and secondary use in military and disaster response settings. Distribution is conducted via direct institutional B2B sales, and AiimSense is actively pursuing clinical trials, regulatory pathways, and commercialization partnerships. Specific pricing is not publicly disclosed; enterprise medical device pricing is typically custom and configuration-dependent.

AiimSense maintains research collaborations with the University of Waterloo (founding institution), McMaster University, and the University of Toronto, providing engineering and clinical expertise. The company markets itself primarily through its website, LinkedIn, and X (Twitter), and routes investor and partnership inquiries through dedicated email channels ([email protected], [email protected]). It was accepted into the WeSEED cohort on 2025-05-06, though no associated capital amount has been disclosed.

Name

AiimSense

Legal name

AiimSense Inc.

Website

https://aiimsense.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

AiimSense is a Canadian medical device startup that has developed BrainScreen™, a portable, AI-enabled electromagnetic brain scanner for real-time stroke and traumatic brain injury detection at the point of care, targeting hospitals, EMS, rural clinics, and military or disaster response settings.

Ownership category

akta.pro rank

Product category

Portable Medical Imaging Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

akta.pro secondary industries

Medical Imaging AI (HDAAAEAH), Biosensors & Lab-on-Chip (BioMEMS) (HDAHALAK)

Keywords

• Portable brain imaging
• Electromagnetic tomography
• Stroke detection devices
• Medical imaging devices
• AI diagnostic imaging

Headquarters

HQ city

Kitchener

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

AiimSense develops and manufactures BrainScreen™, a lightweight, portable brain scanner that combines electromagnetic imaging (EMI) with proprietary AI algorithms to detect real-time changes in brain dielectric properties. The device is designed for rapid identification of ischemic and hemorrhagic strokes as well as traumatic brain injuries at the point of care — at the bedside, in ambulances, or in remote clinics — replacing or supplementing time-consuming CT and MRI workflows.

Product overview

AiimSense offers a single unified product—the BrainScreen™ portable brain scanner—which combines electromagnetic imaging technology with AI to provide real-time, bedside brain imaging for rapid stroke and traumatic brain injury detection. The system is designed for use across emergency departments, ambulances, rural communities, and military/disaster response settings, delivering actionable diagnostic insights in minutes rather than the time required by traditional CT or MRI systems.

Differentiator

Problem solved

Functional benefit

Brands

• BrainScreen™: Portable brain scanner device combining electromagnetic imaging with advanced AI to detect strokes (ischemic and hemorrhagic) and traumatic brain injuries.

Products and services

• BrainScreen™ Portable Brain Scanner BrainScreen™ is a lightweight, portable brain scanner that combines electromagnetic imaging with proprietary AI algorithms to detect real-time changes in brain dielectric properties. It is designed for rapid identification of ischemic and hemorrhagic strokes as well as traumatic brain injuries, enabling actionable diagnostic insight in minutes at the bedside, in ambulances, or in remote clinics. It is targeted at healthcare institutions including hospitals, emergency departments, EMS providers, and military/disaster response units.

Quantifiable outcome

• Faster triage compared to traditional CT/MRI imaging systems
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and secondary.

• University of WaterloocoreStrategic or Co-development PartnerAiimSense collaborates with the University of Waterloo as a founding institution. The company was founded at Waterloo and maintains ongoing research collaboration with the university's engineering and science departments.
• McMaster UniversitysecondaryStrategic or Co-development PartnerAiimSense collaborates with McMaster University as part of its network of leading research institutions for technology development and clinical research.
• University of TorontosecondaryStrategic or Co-development PartnerAiimSense collaborates with the University of Toronto as part of its multidisciplinary team integrating academic expertise, engineering innovation, and clinical insight.

Scale indicators1 record

Recent moves5 records

Expansion highlights6 records

Direct peers

• NovaSignal Corporation: Commercial-stage company offering portable, AI-enabled transcranial Doppler ultrasound (NovaGuide / Robocath) for real-time cerebral blood flow assessment in stroke and TBI — directly comparable in the portable brain-monitoring category and clinical use case.
• Hyperfine: Public medtech company (NASDAQ: HYPR) commercializing the Swoop™, a portable, low-field MRI system designed for point-of-care brain imaging at the bedside — directly comparable in portable brain imaging mission, though using a different (MRI) modality.
• EMVision Medical Devices: Australian-listed company developing portable, non-ionizing electromagnetic/microwave imaging devices for rapid stroke and TBI detection at the bedside — closest direct technology analog to AiimSense's BrainScreen™ in target use case, modality, and form factor.
• Infrascan (Infrascanner): Company marketing the Infrascanner, a portable, FDA-cleared near-infrared device for rapid detection of intracranial hematomas in TBI — directly comparable as a portable, non-invasive, point-of-care brain diagnostic targeting similar clinical settings including EMS and military.

Broad incumbents

• Stryker (Neurovascular): Major neurovascular incumbent offering stroke intervention products (e.g., Trevo, AXS Catalyst) sold into the same hospital and stroke-center customers that AiimSense targets — comparable as a broad incumbent with established hospital sales channels.
• GE HealthCare: Global imaging incumbent (CT, MRI, PET) that dominates the brain imaging category AiimSense aims to disrupt at the bedside — comparable as the incumbent whose installed base and clinical workflow integration AiimSense must compete against.
• Philips Healthcare: Major imaging OEM (CT, MRI, IntelliVue patient monitoring) serving the same hospital neurology and stroke workflows — comparable as a broad incumbent with deep hospital sales coverage.
• Siemens Healthineers: Global imaging OEM (CT, MRI including MAGNETOM and SOMATOM lines) competing in the brain imaging space — comparable as a broad incumbent that could itself enter portable/AI-enabled brain imaging.
• Medtronic (Neurovascular): Global leader in neurovascular intervention (stent retrievers, aspiration catheters, stroke intervention devices) — comparable as a broad incumbent operating across the stroke care continuum, including adjacent diagnostic and therapeutic products used by the same clinical customers.

Emerging players

• Ceribell: Commercial-stage company offering portable, AI-enabled EEG (Point-of-Care EEG, Clarity Algorithm) for rapid neurological assessment in hospital and EMS settings — comparable as an emerging player in portable, AI-driven brain diagnostics targeting overlapping ED/ICU and pre-hospital customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/aiimsense
• LinkedInlinkedin.com/company/aiimsense

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AiimSense